The target INR range for patients on warfarin therapy varies depending on their condition but is typically between 2.0 and 3.0.

Frequency of testing depends on individual patient needs, but initially, it may be done weekly or bi-weekly until stable, then less frequently thereafter.

Yes, the PT / INR Test can help diagnose various clotting disorders, including those related to liver disease or genetic clotting factor deficiencies.

Medications, dietary changes, liver function, and underlying health conditions can all influence PT / INR results.

Yes, the PT / INR Test is a safe and standard diagnostic procedure used worldwide to monitor blood clotting ability and adjust anticoagulant therapy.

Types include vaginal repair, abdominal repair, sacral colpopexy, and hysterectomy with prolapse repair, depending on the severity of the prolapse and individual patient factors.

Bilirubin is a yellowish pigment produced during the breakdown of red blood cells.

It helps diagnose liver disorders, bile duct issues, and conditions affecting red blood cell breakdown.

No special preparation is required. Inform your healthcare provider about any medications or supplements you are taking.

Abnormal levels can indicate liver diseases, bile duct obstruction, or disorders affecting red blood cell breakdown.

Yes, certain medications can influence bilirubin levels. Inform your healthcare provider about any medications you are taking before the test.